PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-kB pathway.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31373750 ↗2019Reported benefit

Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-kB pathway.

RatIschaemia-reperfusionLimb / skeletal muscleSprague-DawleyMalen = n = 7 per group, four groups, 28 rats in totalIntraperitonealDexmedetomidine 25 microg/kg; atipamezole 250 microg/kg in…0.5 hour prior to ischaemia (preconditioning); atipamezole given before dexmede…

Model: Hind limb ischaemia-reperfusion: femoral artery clamped with a non-invasive arterial clip and ligated with rubber bands for 3 hours of ischaemia, followed by 2 hours of reperfusion, producing acute lung injury

Dexmedetomidine preconditioning significantly reduced lung oedema, histological injury, myeloperoxidase activity and BALF and serum IL-1, IL-6 and TNF-alpha relative to ischaemia-reperfusion alone, and lowered TLR4, MyD88, NF-kB and phosphorylated NF-kB expression. Atipamezole partially reversed th…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.